![HSA Guidance on Life Cycle Approach for Software Medical Devices: AI-MD](https://www.regdesk.co/wp-content/uploads/2024/04/HSA-on-software-medical-devices-AI-MD.jpg)
Jun 3, 2024
HSA
The new article describes in detail special regulatory requirements concerning software medical devices utilising Artificial Intelligence technology to ensure the specific risks associated with it are duly addressed.
Read More
![Leveraging RIMS Platforms for Global Market Access](https://www.regdesk.co/wp-content/uploads/2024/05/01-Leveraging-RIMS-for-Global-Market-Access.png)
May 29, 2024
HSA
Global market access is crucial for medical device companies looking to reach new customers, enhance brand recognition worldwide and ultimately increase revenue opportunities. However, expanding operations and reaching new countries can be highly challenging for these...
Read More
![HSA Guidance on Advertisement Controls of Health Products: Overview](https://www.regdesk.co/wp-content/uploads/2024/05/HSA-on-advertising-overview.jpg)
May 28, 2024
HSA
The article provides a general overview of the existing legal framework for advertising healthcare products allowed for marketing and use in Singapore.
Read More
![HSA Guidance on Advertisement Controls of Health Products: Key Aspects](https://www.regdesk.co/wp-content/uploads/2024/05/HSA-on-advertising-key-aspects.jpg)
May 28, 2024
HSA
The new article describes in detail the key aspects related to the advertising activities in the context of medical devices intended to be marketed in Singapore.
Read More
![HSA Guidance on Product Registration Submission](https://www.regdesk.co/wp-content/uploads/2024/04/HSA-on-product-registration-submission.jpg)
May 22, 2024
HSA
The article provides a general overview of the regulatory framework for product registration submissions, including the relevant procedures for applying for marketing approval in Singapore.
Read More